SOLU-CORTEF 250 MG ACT-O-VIAL

What it is

SOLU-CORTEF 250 MG ACT-O-VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as hydrocortisone sodium succinate, under the trade name “Solu-Cortef”.

FDA gives its dosage form as injection, powder, for solution and its route as intramuscular; intravenous.

The labeler, the company named on the label, is Pharmacia & Upjohn Company LLC.

FDA’s Established Pharmacologic Class for it is Corticosteroid.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00009-0013-05.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $51.43 for 1 unit (EA) (1 × $51.43208 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-07-01. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size.

This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-07-01. The file is new; the price is not.

What NADAC measures · NADAC explanation codes · Carried-forward prices

The NDC

• 00009-0013-05 · Pharmacia & Upjohn Company LLC · $51.43208 per EA · eff. 2026-07-01 filed carried forward

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name hydrocortisone sodium succinate with SOLU-CORTEF 250 MG ACT-O-VIAL.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-09-23, 2026-10-01 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

Its NADAC price is $51.43208 per EA filed.

Of the 73 other products in FDA’s Corticosteroid class priced per EA, 9 have a higher middle NADAC price and 64 a lower one. The one in the middle is FLUTICASONE PROP 100 MCG DISKUS, at $2.05252 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part B’s payment limit for HCPCS J1720, for 2026-10-01 to 2026-12-31, comes to $69.45 for 1 unit (EA), or $69.447 per EA once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $4.6298 per 100 MG.

Medicare's price is not your price.

What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
• If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.